These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 25443349)

  • 21. [On the brink of a new era in the treatment of chronic hepatitis C virus infection in Denmark].
    Eiset AH; Holm MP; Leutscher PD
    Ugeskr Laeger; 2014 Jul; 176(30):. PubMed ID: 25292241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of novel regimens for the treatment of hepatitis C virus.
    Najafzadeh M; Andersson K; Shrank WH; Krumme AA; Matlin OS; Brennan T; Avorn J; Choudhry NK
    Ann Intern Med; 2015 Mar; 162(6):407-19. PubMed ID: 25775313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New hepatitis C virus (HCV) drugs and the hope for a cure: concepts in anti-HCV drug development.
    Pawlotsky JM
    Semin Liver Dis; 2014 Feb; 34(1):22-9. PubMed ID: 24782255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Naturopathy consultation. Soon all patients will be curable. Decisive breakthrough in therapy of hepatitis C ].
    Einecke D
    MMW Fortschr Med; 2014 Feb; 156(3):26-7. PubMed ID: 24938054
    [No Abstract]   [Full Text] [Related]  

  • 25. The evolution of the therapeutic strategy in hepatitis C: features of sofosbuvir and indications.
    Alberti A; Piovesan S
    Dig Liver Dis; 2014 Dec; 46 Suppl 5():S174-8. PubMed ID: 25458777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ledipasvir-sofosbuvir plus ribavirin for patients with genotype 1 hepatitis C virus previously treated in clinical trials of sofosbuvir regimens.
    Wyles D; Pockros P; Morelli G; Younes Z; Svarovskaia E; Yang JC; Pang PS; Zhu Y; McHutchison JG; Flamm S; Lawitz E
    Hepatology; 2015 Jun; 61(6):1793-7. PubMed ID: 25846014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigational nucleoside and nucleotide polymerase inhibitors and their use in treating hepatitis C virus.
    Gentile I; Coppola N; Buonomo AR; Zappulo E; Borgia G
    Expert Opin Investig Drugs; 2014 Sep; 23(9):1211-23. PubMed ID: 24848437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of hepatitis C viral kinetics during administration of two nucleotide analogues: sofosbuvir (GS-7977) and GS-0938.
    Guedj J; Pang PS; Denning J; Rodriguez-Torres M; Lawitz E; Symonds W; Perelson AS
    Antivir Ther; 2014; 19(2):211-20. PubMed ID: 24464551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapy of chronic hepatitis C virus infection in the era of direct-acting and host-targeting antiviral agents.
    Conteduca V; Sansonno D; Russi S; Pavone F; Dammacco F
    J Infect; 2014 Jan; 68(1):1-20. PubMed ID: 24012819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Direct-Acting Antivirals for Hepatitis C Virus (HCV): The Progress Continues.
    Feld JJ
    Curr Drug Targets; 2017; 18(7):851-862. PubMed ID: 26302808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Chronic hepatitis C infection--eradication of the virus].
    Ben Ari Z
    Harefuah; 2014 Jul; 153(7):392-3, 433. PubMed ID: 25189028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances in the treatment of hepatitis C.
    Dhingra A; Kapoor S; Alqahtani SA
    Discov Med; 2014 Oct; 18(99):203-8. PubMed ID: 25336034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Case report of successful treatment of fibrosing cholestatic hepatitis C with sofosbuvir and ribavirin after liver transplantation.
    Kim B; Trivedi A; Thung SN; Grewal P
    Semin Liver Dis; 2014 Feb; 34(1):108-12. PubMed ID: 24782264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Daclatasvir plus sofosbuvir for HCV infection: an oral combination therapy with high antiviral efficacy.
    Asselah T
    J Hepatol; 2014 Aug; 61(2):435-8. PubMed ID: 24816173
    [No Abstract]   [Full Text] [Related]  

  • 35. Hepatitis C virus: here comes all-oral treatment.
    Dugum M; O'Shea R
    Cleve Clin J Med; 2014 Mar; 81(3):159-72. PubMed ID: 24591471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The new era of hepatitis C virus therapy.
    Al-Judaibi B
    Saudi J Gastroenterol; 2015; 21(6):345-54. PubMed ID: 26655128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What does the pharmacological future of treating chronic hepatitis C look like?
    Heil EL; Hynicka LM; Kottilil S; Tang L
    Expert Rev Clin Pharmacol; 2015; 8(5):605-22. PubMed ID: 26289223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New expensive treatments for hepatitis C infection.
    Brennan T; Shrank W
    JAMA; 2014 Aug; 312(6):593-4. PubMed ID: 25038617
    [No Abstract]   [Full Text] [Related]  

  • 39. Sofosbuvir (Sovaldi) for hepatitis C virus.
    Lomberk M; Klibanov OM
    Nurse Pract; 2015 Sep; 40(9):16-9. PubMed ID: 26274882
    [No Abstract]   [Full Text] [Related]  

  • 40. Direct-Acting Antiviral Agents: Regimens for the Interferon Failure Patient.
    Kushner T; Khungar V
    Clin Liver Dis; 2015 Nov; 19(4):629-39, v-vi. PubMed ID: 26466652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.